|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.26 DKK | +1.25% |
|
+5.05% | -1.71% |
| 04-13 | Lundbeck to present new neurology data at upcoming congress | FW |
| 03-23 | H. Lundbeck Price Target Down as AlphaValue/Baader Europe Expects Patent Expirations to Weigh on Growth | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 46.12 | +10.51% | 12 | |||||||
| 991.67 | +14.33% | 15 | |||||||
| 248.27 | +16.5% | 15 | |||||||
| 3.251 | +18.64% | 14 | |||||||
| 49.41 | +40% | 8 | |||||||
| 20.58 | +20.1% | 8 | |||||||
| 20.09 | +10.97% | 14 | |||||||
| - | 88 | -2.22% | 6 | ||||||
| 5.78 | +8.24% | 3 | |||||||
| 2,842.5 | +0.53% | 4 | |||||||
| - | 36.43 | +25.66% | 2 | ||||||
| 28.01 | +52.8% | 8 | |||||||
| 6,633.33 | +9.59% | 3 | |||||||
| - | 27.39 | +3.33% | 5 | ||||||
| - | - | - | - | - | |||||
| - | - | 4,800 | +3.99% | 2 | |||||
| Average | 1,056.06 | +15.53% | 8 | ||||||
| Weighted average by Cap. | 659.81 | +15.83% | 13 |
- Stock Market
- Equities
- HLUN B Stock
- Sector H. Lundbeck A/S
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















